321 related articles for article (PubMed ID: 6856288)
21. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.
Prieto M; Gómez MD; Berenguer M; Córdoba J; Rayón JM; Pastor M; García-Herola A; Nicolás D; Carrasco D; Orbis JF; Mir J; Berenguer J
Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423
[TBL] [Abstract][Full Text] [Related]
22. Significance of isolated hepatitis B core antibody in blood donors.
Schifman RB; Rivers SL; Sampliner RE; Krammes JE
Arch Intern Med; 1993 Oct; 153(19):2261-6. PubMed ID: 8215729
[TBL] [Abstract][Full Text] [Related]
23. [Detection of anti-HBc carrier state in blood donors with the Corab kit. Its relationship to anti-HBbrno and hepatitis B virus carrier state].
Pintera J; Krácmar C
Cas Lek Cesk; 1980 Sep; 119(36-37):997-1002. PubMed ID: 7438178
[No Abstract] [Full Text] [Related]
24. Clinical and prognostic values of anti-hepatitis B core immunoglobulin M detection in asymptomatic hepatitis B surface antigen carriers.
Ali HY; Faransawy ZE; Al-Megthab NA
Saudi Med J; 2002 Jul; 23(7):777-81. PubMed ID: 12174223
[TBL] [Abstract][Full Text] [Related]
25. Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma.
Wu JM; Huang YH; Lee PC; Lin HC; Lee SD
J Clin Gastroenterol; 2009; 43(5):496-8. PubMed ID: 19247200
[TBL] [Abstract][Full Text] [Related]
26. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen.
Marusawa H; Uemoto S; Hijikata M; Ueda Y; Tanaka K; Shimotohno K; Chiba T
Hepatology; 2000 Feb; 31(2):488-95. PubMed ID: 10655275
[TBL] [Abstract][Full Text] [Related]
27. Differential localization of s and e antigens in hepatitis B virus-associated glomerulonephritis.
Ohba S; Kimura K; Mise N; Konno Y; Suzuki N; Miyashita K; Tojo A; Hirata Y; Uehara Y; Atarashi K; Goto A; Omata M
Clin Nephrol; 1997 Jul; 48(1):44-7. PubMed ID: 9247778
[TBL] [Abstract][Full Text] [Related]
28. [Prevalence of surface antigens (HBsAg), surface antibody (HBsAb) and anticore antibody (HBcAb) in hospital personnel and patients with and without hepatic pathology].
Ardito D; Bianco T; Demundo T; Loiodice L
Minerva Med; 1980 Oct; 71(39):2815-20. PubMed ID: 7432690
[TBL] [Abstract][Full Text] [Related]
29. [Detection of a class IgM antibody against the core antigen of the hepatitis B virus in patients with chronic infection].
Quiroga JA; Bartolomé J; Carreño V; Mora I; Porres JC; Gutiez J; Hernández Guío C
Rev Clin Esp; 1987 Nov; 181(7):351-5. PubMed ID: 3423340
[No Abstract] [Full Text] [Related]
30. [Significance of the "isolated anti-HBc" serological pattern determinated by the serological response to the vaccination against Hepatitis B].
Coz Yataco A; Lozano Miranda A; Samalvides Cuba F; Antunez de Mayolo Ramis E
Rev Gastroenterol Peru; 2005; 25(3):254-8. PubMed ID: 16237469
[TBL] [Abstract][Full Text] [Related]
31. High titre of antibody to hepatitis B core antigen detected by immune adherence haemagglutination in HBsAg-positive acute hepatitis.
Ikegami F; Takasu S; Jo K; Miyakawa Y; Tsuda F; Mayumi M
Hepatogastroenterology; 1982 Aug; 29(4):142-3. PubMed ID: 7129336
[TBL] [Abstract][Full Text] [Related]
32. A revised method for estimating hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident cases.
Laperche S; Maniez M; Barlet V; El Ghouzzi MH; Le Vacon F; Levayer T; Lunel F; Morel P; Mouillot L; Piquet Y; Pillonel J;
Transfusion; 2008 Nov; 48(11):2308-14. PubMed ID: 18673347
[TBL] [Abstract][Full Text] [Related]
33. Use of the hepatitis B core antigen produced in Escherichia coli in an assay for anti-HBc.
Peutherer JF; MacKay P; Ross R; Stahl S; Murray K
Med Lab Sci; 1981 Oct; 38(4):355-8. PubMed ID: 7035782
[No Abstract] [Full Text] [Related]
34. Immunopathology of chronic hepatitis.
Gerber MA
Monogr Pathol; 1987; (28):54-64. PubMed ID: 3537745
[No Abstract] [Full Text] [Related]
35. [Markers of hepatitis B virus in chronic liver diseases].
Maleev A; Ognianov M; Ninova D
Ter Arkh; 1987; 59(7):13-7. PubMed ID: 3672351
[No Abstract] [Full Text] [Related]
36. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
[TBL] [Abstract][Full Text] [Related]
37. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
[TBL] [Abstract][Full Text] [Related]
38. The significance of IgM antibodies to hepatitis B core antigen in hepatitis B carriers and hepatitis B-associated chronic liver disease.
Feinman SV; Overby LR; Berris B; Chau K; Schable CA; Maynard JE
Hepatology; 1982; 2(6):795-9. PubMed ID: 7141390
[No Abstract] [Full Text] [Related]
39. [Viral hepatitis and pregnancy].
Niesen M; Plotz EJ; Schneweis KE
Gynakologe; 1982 Mar; 15(1):11-7. PubMed ID: 6804318
[No Abstract] [Full Text] [Related]
40. [Modern methods of the diagnosis of serum hepatitis type B].
Ketiladze ES; Vorozhbieva TE; Zhilina NN; Bugaeva NP; Favorov MO
Sov Med; 1979 May; (5):40-4. PubMed ID: 377513
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
